Good morning, everyone, and how are you today? We are just fine, thank you, especially since a shiny sun and cool breeze are enveloping the Pharmalot campus this morning. This also makes for a lovely day to take a few moments to watch the shortest of our short people matriculate among schoolhouses. So please excuse us while we take a midday break to celebrate. Meanwhile, here are some items of interest to keep you focused. Hope your day goes well and, of course, do keep in touch …
Novartis rejected overtures from President Trump to increase jobs in the U.S., citing work visa restrictions for foreign nationals as a reason, according to Swissinfo. “This makes the country a less attractive location for investment,” Novartis chief executive Joe Jimenez explained. “By contrast, Switzerland and Europe will become more attractive.” In the U.S., the company currently has more than 22,000 employees.
About the Author Reprints
Jimeniz is blowing smoke up Trump’s tail pipe. For every H1B visa foreign pharma worker there are qualified Americans standing in line. As my wife used to joke “it’s Swiss!”